Major IV drip producer unlikely to resume production soon: TFDA

Taiwan's shortage of intravenous (IV) fluid looks set to continue for at least several months, after officials announced Wednesday that the country's largest producer was unlikely to resume production before next year.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)